GH Research (GHRS) Current Assets (2021 - 2025)

GH Research (GHRS) recorded quarterly Current Assets of $286.0 million in Q4 2025, down 2.99% quarter-over-quarter from $294.8 million in Q3 2025, and up 85.43% on a YoY basis from $154.2 million in Q4 2024.

GH Research (GHRS) Current Assets (2021 - 2025) Analysis & Trends

GH Research's Current Assets history runs 5 years deep, the most recent figure standing at $286.0 million for Q4 2025.

  • In Q4 2025, Current Assets rose 85.43% year-over-year to $286.0 million; the TTM figure through Dec 2025 stood at $286.0 million (up 85.43% YoY), while the FY2025 annual figure was $286.0 million, up 85.43% from the prior year.
  • Current Assets was $286.0 million for Q4 2025 at GH Research, down from $294.8 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $294.8 million in Q3 2025 to a low of $152.9 million in Q2 2024.
  • Historically, Current Assets has averaged $215.1 million across 5 years, with a median of $167.5 million in 2022.
  • The sharpest annual moves came in 2023 and 2025: Current Assets slumped 39.77% in 2023, then soared 92.19% in 2025.
  • A 5-year view of Current Assets shows it stood at $166.0 million in 2021, then increased by 1.51% to $168.5 million in 2022, then declined by 2.64% to $164.1 million in 2023, then fell by 6.01% to $154.2 million in 2024, then surged by 85.43% to $286.0 million in 2025.
  • The last three Current Assets figures came in at $286.0 million (Q4 2025), $294.8 million (Q3 2025), and $293.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 37.31 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 521.86 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 10.37 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 1.25 Bn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 3.59 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 7.63 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 11.73 Bn
9 Abivax 94.26 Bn 94.26 Bn - 600.85 Mn
10 GH Research 9.73 Bn 9.63 Bn - 285.98 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 285.98 Mn
Sep 30, 2025 294.79 Mn
Jun 30, 2025 293.88 Mn
Mar 31, 2025 294.67 Mn
Dec 31, 2024 154.23 Mn
Sep 30, 2024 154.95 Mn
Jun 30, 2024 152.91 Mn
Mar 31, 2024 160.48 Mn
Dec 31, 2023 164.09 Mn
Sep 30, 2023 164.04 Mn
Jun 30, 2023 166.40 Mn
Mar 31, 2023 164.72 Mn
Dec 31, 2022 168.54 Mn
Sep 30, 2022 260.04 Mn
Jun 30, 2022 266.23 Mn
Mar 31, 2022 273.46 Mn
Dec 31, 2021 166.03 Mn
Sep 30, 2021 285.56 Mn